---
title: 'Executive Director, People Business Partnership at Acadia Pharmaceuticals Inc.'
canonical: 'https://feeny.ai/job/executive-director-people-business-partnership-acadia-pharmaceuticals-inc-cmq0hqe2geb6'
type: 'job'
last_seen: '2026-11-02'
---

# Executive Director, People Business Partnership at Acadia Pharmaceuticals Inc.

- **Company:** Acadia Pharmaceuticals Inc.
- **Location:** Princeton, NJ / San Diego, CA
- **Compensation:** $261k–$326k
- **Posted:** 2026-10-22
- **Last confirmed live:** 2026-11-02
- **Apply:** https://acadia.com/en-us/careers/job-board/8906832002?gh_jid=8906832002

## Job description

## About Acadia Pharmaceuticals

Acadia is committed to turning scientific promise into meaningful innovation that makes the difference for underserved neurological and rare disease communities around the world. Our commercial portfolio includes the first and only FDA-approved treatments for Parkinson’s disease psychosis and Rett syndrome. We are developing the next wave of therapeutic advancements with a robust and diverse pipeline that includes mid- to late-stage programs in Alzheimer’s disease psychosis and Lewy body dementia psychosis, along with earlier-stage programs that address other underserved patient needs. At Acadia, we’re here to be their difference.

Please note that this position is based in either San Diego, CA, or Princeton, NJ. Acadia's hybrid model requires this role to work in our office three days per week on average.

Position Summary

The Executive Director, People Business Partnership leads Acadia’s People Business Partner team and serves as a senior advisor to business and People & Performance leadership. The role translates business strategy into clear organization, workforce, leadership and talent priorities that enable Acadia’s growth and performance.

This leader strengthens the quality, consistency and business impact of People Business Partnership across Acadia. Working with business leaders, PBPs and People & Performance Centers of Excellence, the Executive Director anticipates organizational needs, shapes workforce and capability plans, improves leadership effectiveness and enables successful change.

The successful candidate combines strong business judgment with deep expertise in organization, talent, workforce planning and change. This leader raises PBP capability, clarifies ownership, reduces operational burden and focuses the team on the highest-value business and organizational priorities.

Primary Responsibilities

PBP Leadership & Business Partnership

- Lead and develop Acadia’s People Business Partner team, setting clear expectations, building capability and ensuring consistent, high-quality support to leaders.
- Develop a deep understanding of Acadia’s strategy, growth priorities and operating environment, and translate them into workforce, organization, leadership and talent implications.
- Serve as a senior advisor to business and P&P leaders on organization effectiveness, workforce planning, leadership, talent, culture and significant organizational change.
- Guide PBPs in creating focused people plans linked to business priorities and measurable organizational outcomes.

Organization, Workforce & Talent Strategy

- Partner with leaders to identify the capabilities, roles, structures and talent required to deliver current priorities and prepare for future growth.
- Build a forward-looking workforce planning approach that informs where to build, buy, deploy or access critical capabilities.
- Lead organization design and effectiveness work involving structures, roles, governance, decision-making and ways of working.
- Partner with Talent Management and leaders to strengthen succession, talent planning, leadership pipelines and future capabilities.

Leadership Effectiveness & Change

- Strengthen leadership effectiveness through trusted advice, coaching, organizational insights and practical support.
- Enable organizational change by clarifying the business rationale, assessing workforce impacts, building leadership alignment and sustaining adoption.
- Support complex and consequential people matters with Employee Relations, Legal and other specialists to ensure balanced, compliant and business-oriented decisions.

Operating Model, Insights & Enterprise Partnership

- Partner with P&P Centers of Excellence and Operations to create scalable solutions, tools, processes and insights that improve the manager and employee experience.
- Clarify ownership across PBPs, Centers of Excellence, People Operations and business leaders so PBPs can focus on strategic priorities rather than transactional activity.
- Use workforce data, business indicators, market intelligence and organizational insights to identify emerging needs and improve decisions.
- Partner with Total Rewards to inform talent investments and contribute to the evolution of Acadia’s P&P operating model, accountability and business impact.
- Perform other duties and responsibilities as assigned.

Measures of Success

- A high-performing PBP team that delivers consistent, strategic and business-focused partnership.
- Clear people plans aligned to enterprise and functional priorities.
- Stronger workforce, organization, leadership and talent decisions supported by trusted insights.
- Reduced transactional burden and clearer accountability across PBPs, Centers of Excellence and People Operations.
- Effective organizational change and stronger leadership capability across the business.

Education, Experience & Skills

- Bachelor’s degree in human resources, Business Administration, Organizational Development or a related field, with 15+ years of progressive P&P, Human Resources or related leadership experience, including 8+ years leading teams and enterprise-wide people initiatives. An advanced degree is preferred; an equivalent combination of education and experience may be considered.
- Proven experience leading a senior PBP team and advising executive leaders in biotechnology, pharmaceutical, healthcare or another highly regulated environment.
- Strong business acumen and demonstrated ability to translate strategy into workforce, organization, leadership, talent and change priorities.
- Demonstrated success in organization design, workforce planning, talent and succession planning, leadership development and large-scale change.
- Ability to use workforce data, business indicators, organizational insights and market intelligence to influence decisions and outcomes.
- Experience delivering outcomes through senior business partners, cross-functional teams and Centers of Excellence, while clarifying operating-model accountabilities and shifting transactional work to the appropriate channels.
- Sound judgment in complex people matters, with working knowledge of employment law, employee relations, performance management and organizational risk.
- Exceptional executive communication, coaching, facilitation, negotiation and stakeholder-management skills; demonstrated ability to build accountable, inclusive and collaborative teams.
- Experience supporting geographically dispersed teams in a fast-paced, growth-oriented environment. Ability to travel up to 25%, primarily within the United States.

Physical Requirements

This role involves regular standing, walking, sitting, and the use of hands for handling or operating equipment. The employee may also need to reach, climb, balance, stoop, kneel, crouch, and maintain visual, verbal and auditory communication in a standard office environment and while working independently from remote locations. The employee must occasionally lift and/or move up to 20 pounds. This position requires the ability to travel independently overnight and/or work after hours as required by travel schedules or business needs.

## #LI-HYBRID #LI-CT1

In addition to a competitive base salary, this position is also eligible for discretionary bonus and equity awards based on factors such as individual and organizational performance. Actual amounts will vary depending on experience, performance, and location.

Salary Range $261,000—$326,300 USD

What we offer US-based Employees:

- Competitive base, bonus, new hire and ongoing equity packages
- Medical, dental, and vision insurance
- Employer-paid life, disability, business travel and EAP coverage
- 401(k) Plan with a fully vested company match 1:1 up to 5%
- Employee Stock Purchase Plan with a 2-year purchase price lock-in
- 15+ vacation days
- 13 -15 paid holidays, including office closure between December 24th and January 1st
- 10 days of paid sick time
- Paid parental leave benefit
- Tuition assistance

EEO Statement (US-based Employees): Studies have shown that women and people of color are less likely to apply for jobs unless they believe they meet every one of the qualifications in the exact way they are described in job postings. We are committed to building a diverse, equitable, inclusive, and innovative company, and we are looking for the BEST candidate for the job. That candidate may be one who comes from a less traditional background or may meet the qualifications in a different way. We strongly encourage you to apply, especially if the reason you are the best candidate isn’t exactly what we describe here.

It is the policy of Acadia to provide equal employment opportunities to all employees and employment applicants without regard to considerations of race, including related to hairstyle, color, religion or religious creed, sexual orientation, gender, gender identity, gender expression, gender transition, country of origin, ancestry, citizenship, age, physical or mental disability, genetic information, legally-protected medical condition or information, marital status, domestic partner status, family care status, military caregiver status, veteran or military status (including reserve status, National Guard status, and military service or obligation), status as a victim of domestic violence, sexual assault or stalking, enrollment in a public assistance program, or any basis protected under federal, state or local law.

As an equal opportunity employer, Acadia is committed to a diverse workforce. If you are a qualified individual with a disability or a disabled veteran, you have the right to request a reasonable accommodation. Furthermore, you may request additional support if you are unable or limited in your ability to use or access Acadia’s career website due to your disability, along with any accommodations throughout the interview process. To request or inquire about your reasonable accommodation, please complete our [Reasonable Accommodation Request Form](https://app.smartsheet.com/b/form/43db301ada19415fa7ab365633993f33) or contact us at talentacquisition@acadia-pharm.com or 858-261-2923.

Please note that reasonable accommodations granted throughout the recruiting process are not guaranteed to be the same accommodations given if hired. A new request will need to be submitted for any ADA accommodations after starting employment.

California Applicants: Please see [Additional Information for California Residents](https://acadia.com/en-us/legal-policies/privacy#18) within our Privacy Policy.

Canadian Applicants: Please see [Additional Information for Canadian Residents](https://acadia.com/en-gb/legal-policies/privacy#17) within our Privacy Policy.

Applicants in the European Economic Area, Switzerland, the United Kingdom, and Serbia: Please see [Additional Information for Individuals in the European Economic Area, Switzerland, the United Kingdom, and Serbia](https://acadia.com/en-gb/legal-policies/privacy#16) within our Privacy Policy.

Notice to Search Firms/Third-Party Recruitment Agencies (Recruiters): The Talent Acquisition team manages the recruitment and employment process for Acadia Pharmaceuticals Inc. (“Acadia”). Acadia does not accept resumes from recruiters or search firms without an executed search agreement in place. Resumes sent to Acadia employees in the absence of an executed search agreement will not obligate Acadia in any way with respect to the future employment of those individuals or potential remuneration to any recruiter or search firm. Candidates should never be submitted directly to our hiring managers or employees.

## About Acadia Pharmaceuticals Inc.

## Company Overview
- **One-liner**: Acadia Pharmaceuticals is a biopharmaceutical company focused on turning scientific promise into meaningful innovation for underserved neurological and rare disease communities.
- **Entity Type**: Public (NASDAQ: ACAD)
- **Headquarters**: San Diego, California, USA (with additional offices in Princeton, NJ; Oakville, Canada; Zug and Basel, Switzerland; Amsterdam, Netherlands) [acadia.com](https://acadia.com/en-us/about)
- **Founded**: 1993 [acadia.com](https://acadia.com/en-us/about) (schema.org data)
- **Founders**: Not publicly available from provided sources

## Core Business
- **Primary industry**: Biopharmaceuticals – neurological disorders and rare diseases
- **Target customers**: Healthcare providers, patients, and caregivers dealing with Parkinson’s disease psychosis (PDP) and Rett syndrome; also developing therapies for Alzheimer’s disease psychosis, Lewy body dementia, major depressive disorder, essential tremor, and other conditions.
- **Mission/Purpose**: “Be Their Difference” – advancing brighter futures for those living with neurological disorders and rare diseases, guided by science and shaped by patient insight. [acadia.com](https://acadia.com/en-us/careers)

## Products & Services
- **NUPLAZID (pimavanserin)** – First and only FDA-approved therapy for hallucinations and delusions associated with Parkinson’s disease psychosis (PDP). Commercial drug, small molecule. [sec.gov Annual Report](https://www.sec.gov/Archives/edgar/data/1070494/000119312526174167/acad_2025_annual_report.pdf)
- **DAYBUE (trofinetide)** – First and only FDA-approved therapy for Rett syndrome. Commercial drug. [sec.gov Annual Report](https://www.sec.gov/Archives/edgar/data/1070494/000119312526174167/acad_2025_annual_report.pdf)
- **DAYBUE STIX** – Powder formulation of trofinetide, approved in 2025 based on patient feedback, offering flexibility and portability. [sec.gov Annual Report](https://www.sec.gov/Archives/edgar/data/1070494/000119312526174167/acad_2025_annual_report.pdf)
- **Remlifanserin (ACP-204)** – Late-stage pipeline candidate for Alzheimer’s disease psychosis (ADP) and Lewy body dementia psychosis (LBDP). Phase 2 studies initiated. [sec.gov Annual Report](https://www.sec.gov/Archives/edgar/data/1070494/000119312526174167/acad_2025_annual_report.pdf)
- **ACP-211** – Phase 2 candidate for major depressive disorder (MDD). [sec.gov Annual Report](https://www.sec.gov/Archives/edgar/data/1070494/000119312526174167/acad_2025_annual_report.pdf)
- **ACP-711** – Early-stage candidate for essential tremor. [sec.gov Annual Report](https://www.sec.gov/Archives/edgar/data/1070494/000119312526174167/acad_2025_annual_report.pdf)
- Additional early-stage research programs in neurological and rare diseases.

## Market Standing
- **Valuation/Market Cap**: Not publicly available from provided sources. The company ended 2025 with $820 million in cash. [sec.gov Annual Report](https://www.sec.gov/Archives/edgar/data/1070494/000119312526174167/acad_2025_annual_report.pdf)
- **Key Metric**: **$1.07 billion total revenue in 2025** (first time exceeding $1 billion). NUPLAZID net sales: $680 million (up 12% YoY); DAYBUE net sales: $391 million (up 12% YoY). [sec.gov Annual Report](https://www.sec.gov/Archives/edgar/data/1070494/000119312526174167/acad_2025_annual_report.pdf)
- **Notable Investors/Partners**: Not listed in provided sources. As a public company, institutional and retail shareholders.
- **Growth Signals**:
  - Surpassed $1B revenue milestone.
  - FDA approval of DAYBUE STIX (patient-informed formulation).
  - 40% of NUPLAZID prescribers in 2025 were new to the brand.
  - DAYBUE approved in U.S., Canada, Israel; named-patient programs in additional countries.
  - Initiated Phase 2 studies for remlifanserin (ADP, LBDP) and ACP-211 (MDD).
  - Combined peak sales opportunity for four key pipeline assets estimated at ~$11 billion.
  - Over 100,000 patients treated with NUPLAZID in U.S. since launch; ~1,000 active DAYBUE patients globally. [sec.gov Annual Report](https://www.sec.gov/Archives/edgar/data/1070494/000119312526174167/acad_2025_annual_report.pdf)

## Competitive Advantages
- **First-to-market position** in two underserved indications: the only FDA-approved therapies for PDP (NUPLAZID) and Rett syndrome (DAYBUE).
- **Strong commercial portfolio** generating over $1B in annual revenue and growing.
- **Diverse pipeline** targeting large, high-unmet-need markets with differentiated mechanisms (e.g., Alzheimer’s disease psychosis, which has no approved therapy).
- **Patient-centric approach** (DAYBUE STIX developed from direct caregiver feedback) and deep expertise in neurology and rare diseases.
- **Global expansion** capabilities and established regulatory pathways in multiple regions.

## Strategic Focus
- **Accelerate growth** of NUPLAZID and DAYBUE in the U.S. by expanding prescriber base, improving diagnosis rates, and launching new formulations.
- **Advance global access** through regulatory approvals in new markets and named-patient programs.
- **Progress pipeline** toward late-stage trials, particularly remlifanserin for Alzheimer’s disease psychosis (Phase 2) and Lewy body dementia psychosis, as well as ACP-211 for MDD.
- **Build organizational capabilities** for scale: strengthened leadership team, operational excellence, and disciplined capital allocation (ended 2025 with $820M cash). [sec.gov Annual Report](https://www.sec.gov/Archives/edgar/data/1070494/000119312526174167/acad_2025_annual_report.pdf)

## Why Work Here
- **Culture & Purpose**: “Be Their Difference” – employees are driven by a mission to bring therapies to patients with few or no options. [acadia.com Careers](https://acadia.com/en-us/careers)
- **DEIB Commitment**: Diversity, Equity, Inclusion & Belonging is core to the work environment; diverse perspectives are cited as driving curiosity and innovation. [acadia.com DEIB](https://acadia.com/en-us/careers)
- **Total Rewards**: Competitive compensation, benefits, and programs designed to support employees and their families. [acadia.com Why Acadia](https://acadia.com/en-us/careers)
- **Work Flexibility**: Job listings indicate both **hybrid** and **remote** options available. [acadia.com Job Board](https://acadia.com/en-us/careers/job-board)
- **Growth Environment**: A company that went from ~$958M to >$1B revenue in one year, with a deep pipeline and global expansion – offering opportunity for career development in a high-impact therapeutic area.
- **Collaborative & Resourceful**: “Independent thinking and resourceful collaboration” highlighted as values; every role is seen as contributing to the mission. [acadia.com Job Board](https://acadia.com/en-us/careers/job-board)
- **Beware of recruitment scams**: The company notes that legitimate recruiters only use @acadia-pharm.com email domains and do not request personal info like SSN or payments. [acadia.com Job Board](https://acadia.com/en-us/careers/job-board)

## Sources
1. [acadia.com – About & Company Info](https://acadia.com/en-us/about)
2. [acadia.com – Careers Page](https://acadia.com/en-us/careers)
3. [acadia.com – Job Board / Current Openings](https://acadia.com/en-us/careers/job-board)
4. [SEC.gov – Acadia Pharmaceuticals 2025 Annual Report (10-K)](https://www.sec.gov/Archives/edgar/data/1070494/000119312526174167/acad_2025_annual_report.pdf)
5. [acadia.com – News Release: Q1 2026 Financial Results](https://acadia.com/en-us/media/news-releases/acadia-pharmaceuticals-reports-first-quarter-2) (referenced)

## Other roles at Acadia Pharmaceuticals Inc.

- [LTC Patient Access Manager - Northeast](https://feeny.ai/job/ltc-patient-access-manager-northeast-acadia-pharmaceuticals-inc-massachusetts-h0p2agyz5498) — Massachusetts / New Jersey / Pennsylvania / Rhode Island
- [Sr. Director, Regulatory Affairs, Technology & Transformation](https://feeny.ai/job/sr-director-regulatory-affairs-technology-transformation-acadia-pharmaceuticals-q5js4ccv30cv) — Princeton, NJ / San Diego, CA / South San Francisco, CA
- [Manager, Regulatory Affairs, Operations](https://feeny.ai/job/manager-regulatory-affairs-operations-acadia-pharmaceuticals-inc-princeton-kr6x5q8rv611) — Princeton, NJ / San Diego, CA / South San Francisco, CA
- [Sr. Manager Quality Audit and Compliance](https://feeny.ai/job/sr-manager-quality-audit-and-compliance-acadia-pharmaceuticals-inc-princeton-npt6dpn3atsd) — Princeton, NJ / San Diego, CA
- [Executive Director, People & Performance Technology & Operations](https://feeny.ai/job/executive-director-people-performance-technology-operations-acadia-anx50h526mtr) — Princeton, NJ / San Diego, CA
- [Area Business Manager - Dallas, TX](https://feeny.ai/job/area-business-manager-dallas-tx-acadia-pharmaceuticals-inc-texas-hfx7s0g2n0hw) — Texas
- [Neuroscience Regional Sales Manager - Pacific](https://feeny.ai/job/neuroscience-regional-sales-manager-pacific-acadia-pharmaceuticals-inc-south-zr1xrtzw2ynp) — South San Francisco, CA
- [Executive Neuroscience Sales Specialist - Richmond, VA](https://feeny.ai/job/executive-neuroscience-sales-specialist-richmond-va-acadia-pharmaceuticals-inc-gkprf5y5t0pb) — Virginia
- [Associate Director, Regulatory Operations](https://feeny.ai/job/associate-director-regulatory-operations-acadia-pharmaceuticals-inc-princeton-0psrbfgmrp11) — Princeton, NJ / San Diego, CA / South San Francisco, CA
- [Executive Long-Term Care Sales Specialist - Louisville, KY](https://feeny.ai/job/executive-long-term-care-sales-specialist-louisville-ky-acadia-pharmaceuticals-hnd5p2zkp5rc) — Indiana